. In this study Ikeda et al. observed that tenascin, which is not expressed in the adult mucosal and submucosal connective tissue of the stomach, is expressed in the fibrous stroma surrounding foci of cancer in 41% of primary tumours and 32% of lymph node metastases (Ikeda et al., 1995) . They also observed that tenascin expression did not correlate with any of the parameters evaluated in the study, namely the degree of differentiation, abundance of fibrous stroma, depth of invasion, lymph node metastasis and prognosis.
We concur that their results show that 'tenascin appears during the process of either malignant transformation or tumour progression' (Ikeda et al., 1995 (Ikeda et al., 1995) . Firstly, they did not study precursor lesions of gastric carcinoma, either as isolated lesions or as lesions in the periphery of carcinomas, and thus missed the first steps of gastnc carcinogenesis. Secondly, they did not include in their study the analysis of non-cancerous conditions that may induce the expression of tenascin (e.g. peptic ulcers with granulation tissue and marked remodelling of the connective tissue).
We raise these issues because we found that the aforementioned conditions may cause false-positive results when dealing with markers with oncofetal potential, such as the so-called oncofetal fibronectin (onf-FN), an isoform of fibronectin that some authors claim to be specifically associated with malignant transformation (Matsuura and Hakomori, 1989; London-Rosa et al., 1990; Mandel et al., 1992) . At variance with fibronectin, which is widely distributed in normal tissues and particularly prominent in the granulation tissue of ulcerated areas of gastric carcinomas (David et al., 1994) , onf-FN was thought to appear exclusively in the stroma of cancers, thus leading to the possibility of using its detection in the diagnosis of the initial steps of carcinogenesis (Loridon-Rosa et al., 1990; Mandel et al., 1992) . This is not the case because, apart from its presence in gastric carcinoma, we observed strong immunostaining for onf-FN at the base of the three peptic ulcers included in our study (David et al., 1993) . Our findings thus show that the production of onf-FN is not strictly associated with malignancy, being dependent on a variety of conditions having in common the capacity to induce deposition and/or remodelling of extracellular matrix. We wonder whether this is also the case for the expression of tenascin. 
